SWOG clinical trial number

CTSU/NRG-GY016

A Phase II Study of MK-3475 (Pembrolizumab) + epacadostat in Recurrent Clear Cell Carincoma of the Ovary

Closed

Abbreviated Title

A Phase II Study of MK-3475 (Pembrolizumab) + epacadostat in Recurrent Clear Cell Carincoma of the Ovary

Activated

09/28/2018

Closed

02/01/2021

Research committees

Early Therapeutics & Rare Cancers

Gynecologic Cancer